Protein-tyrosine phosphatase, nonreceptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 7, 2004, Pages 3359-3364

  Yoshida, Rie ^a,j   Hasegawa, Tomonobu ^a   Hasegawa, Yukihiro ^b   Nagai, Toshiro ^c   Kinoshita, Eiichi ^d   Tanaka, Yoko ^e   Kanegane, Hirokazu ^f   Ohyama, Kenji ^g   Onishi, Toshikazu ^h   Hanew, Kunihiko ⁱ   Okuyama, Torayuki ^j   Horikawa, Reiko ^j   Tanaka, Toshiaki ^j   Ogata, Tsutomu ^j  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Div of Endocrinology and Metabolism   (Japan)

^c DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOKYO DENTAL COLLEGE   (Japan)

^f UNIVERSITY OF TOYAMA   (Japan)

^g UNIVERSITY OF YAMANASHI   (Japan)

^h TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

ⁱ Hanew Endocrine Clinic   (Japan)

^j NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR TYPE 11; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BLEEDING TENDENCY; CHILD; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; EXON; FEMALE; GENE DELETION; GENE MUTATION; HEART ATRIUM SEPTUM DEFECT; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; JUVENILE MYELOMONOCYTIC LEUKEMIA; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NOONAN SYNDROME; PRIORITY JOURNAL; PULMONARY VALVE STENOSIS; SEQUENCE ANALYSIS; SEX DIFFERENCE;

ADOLESCENT; ADULT; BODY HEIGHT; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE DELETION; GROWTH; HEMATOLOGIC DISEASES; HUMANS; INCIDENCE; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUTATION; MUTATION, MISSENSE; NOONAN SYNDROME; PROTEIN-TYROSINE-PHOSPHATASE; PULMONARY VALVE STENOSIS;

EID: 3242739935     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032091     Document Type: Article

References (38)

1. Mendez HM, Opitz JM 1985 Noonan syndrome: a review. Am J Med Genet 21:493-506
2. Sharland M, Burch M, McKenna WM, Paton MA 1992 A clinical study of Noonan syndrome. Arch Dis Child 67:178-183
3. Witt DR, Hoyme HE, Zonana J, Manchester DK, Fryns JP, Stevenson JG, Curry CJ, Hall JG 1987 Lymphedema in Noonan syndrome: clues to pathogenesis and prenatal diagnosis and review of the literature. Am J Med Genet 27:841-856
4. Bader-Meunier B, Tchernia G, Mielot F, Fontaine JL, Thomas C, Lyonnet S, Lavergne JM, Dommergues JP 1997 Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr 130:885-889
5. Fukuda M, Horibe K, Miyajima Y, Matsumoto K, Nagashima M 1997 Spontaneous remission of juvenile chronic myelomonocytic leukemia in an infant with Noonan syndrome. J Pediatr Hematol Oncol 19:177-179
6. Choong K, Freedman MH, Chitayat D, Kelly EN, Taylor G, Zipursky A 1999 Juvenile myelomonocytic leukemia and Noonan syndrome. J Pediatr Hematol Oncol 21:523-527
7. Silvio F, Carlo L, Elena B, Nicoletta B, Daniela F, Roberto M 2002 Transient abnormal myelopoiesis in Noonan syndrome. J Pediatr Hematol Oncol 24:763-764
8. Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD 2001 Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465-468
9. Ahmad S, Banville D, Zhao Z, Fischer EH, Shen SH 1993 A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains. Proc Natl Acad Sci USA 90:2197-2201
10. Feng G 1999 Shp-2 tyrosine phosphatase: signaling one cell or many. Exp Cell Res 253:47-54
11. Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE 1998 Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441-450
12. Tartaglia M, Niemeyer CM, Fragale A, Song X, Buechner J, Jung A, Hahlen K, Hasle H, Licht JD, Gelb BD 2003 Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia. Nat Genet 34:148-150
13. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, Van Der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD 2002 PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet 70:1555-1563
14. Kosaki K, Suzuki T, Muroya K, Hasegawa T, Sato S, Matsuo N, Kosaki R, Nagai T, Hasegawa Y, Ogata T 2002 PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome. J Clin Endocrinol Metab 87:3529-3533
15. Maheshwari M, Belmont J, Fernbach S, Ho T, Molinari L, Yakub I, Yu F, Combes A, Towbin J, Craigen WJ, Gibbs R 2002 PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13. Hum Mut 20:298-304
16. Musante L, Kehl HG, Majewski F, Meinecke P, Schweiger S, Gillessen-Kaesbach G, Wieczorek D, Hinkel GK, Tinschert S, Hoeltzenbein M, Ropers HH, Kalscheuer VM 2002 Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome. Eur J Hum Genet 11:201-206
17. Schollen E, Matthijs G, Gewillig M, Fryns JP, Legius E 2003 PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning. Eur J Hum Genet 11:85-88
18. Sarkozy A, Conti E, Seripa D, Digilio MC, Grifone N, Tandoi C, Fazio VM, Di Ciommo V, Marino B, Pizzuti A, Dallapiccola B 2003 Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes. J Med Genet 40:704-708
19. Yoshida R, Miyata M, Nagai T, Yamazaki T, Ogata T, A 3 bp deletion mutation of PTPN11 in an infant with severe Noonan syndrome including hydrops fetalis and juvenile myelomonocytic leukemia. Am J Med Genet, in press
20. van der Burgt I, Berends E, Lommen E, van Beersum S, Hamel B, Mariman E 1994 Clinical and molecular studies in a large Dutch family with Noonan syndrome. Am J Med Genet 53:187-191
21. Suwa S, Tachibana K, Maesaka H, Tanaka T, Yokoya S 1992 Longitudinal standards for height and height velocity for Japanese children from birth to maturity. Clin Pediatr Endocrinol 1:5-14
22. Kagami M, Tanaka T, Ogata T, Target height and target range for the Japanese: revisited. Proc of the 37th Annual Meeting of the Japanese Society for Pediatric Endocrinology, Sapporo, Japan, 2003, p 99 (Abstract O-32)
23. Hasle H, Niemeyer CM, Chessells JM, Baumann I, Bennett JM, Kerndrup G, Head DR 2003 A pediatric approach to the WHO classification of myelodys-plastic and myeloproliferative diseases. Leukemia 17:277-282
24. Ito J, Tanaka T, Horikawa R, Okada Y, Morita S, Koitaji M, Tanae A, Hibi I 1993 Serum LH and FSH levels during GnRH tests and sleep in children. J Jpn Pediatr Soc 97:1789-1796 (in Japanese)
25. Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B 2002 Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 71:389-394
26. Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberger C, Gewillig M, Fryns JP 2002 PTPN11 mutations in LEOPARD syndrome. J Med Genet 39:571-574
27. Ranke MB, Heidemann P, Knupfer C, Enders H, Schmaltz AA, Bierich JR 1988 Noonan syndrome: growth and clinical manifestations in 144 cases. Eur J Pediatr 148:220-227
28. Tanner JM, Goldstein H, Whitehouse RH 1970 Standards for children's height at ages 2-9 years allowing for heights of parents. Arch Dis Child 45:755-762
29. Frearson JA, Alexander DR 1997 The role of phosphotyrosine phosphatases in haematopoietic cell signal transduction. Bioessays 19:417-427
30. Arico M, Biondi A, Pui CH 1997 Juvenile myelomonocytic leukemia. Blood 90:479-488
31. Loh ML, Vattikuti S, Schubbert S, Reynolds MG, Carlson E, Lieuw KH, Cheng JW, Lee CM, Stokoe D, Bonifas JM, Curtiss NP, Gotlib J, Meshinchi S, Le Beau MM, Emanuel PD, Shannon KM 2004 Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood 103:2325-2331
32. Grumbach MM, Hughes IA, Conte FA 2003 Disorders of sex differentiation. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams text-book of endocrinology, 10th ed. Philadelphia: Saunders; 842-1002
33. Stofega MR, Herrington J, Billestrup N, Carter-Su C 2000 Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B. Mol Endocrinol 14:1338-1350
34. Cohen P, Clemmons DR, Rosenfeld RG 2000 Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res 10:297-305
35. Kelnar CJ 2000 Growth hormone therapy in Noonan syndrome. Horm Res 53(Suppl 1):77-81
36. Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD 1985 Noonan syndrome: the changing phenotype. Am J Med Genet 21:507-514
37. Coppin BD, Temple IK 1997 Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis). J Med Genet 34:582-586
38. Maron BJ 2001 Hypertrophic cardiomyopathy. In: Allen HD, Gutgesell HP, Clark EB, Driscoll DJ, eds. Moss and Adam's heart disease in infants, children, and adolescents, 6th ed. Baltimore: Lippincott Williams & Wilkins; 1167-1186